![Quiver Logo](/static/img/logo-icon.png)
![ADAG logo](https://quiver-logos.s3.us-east-2.amazonaws.com/adag.png)
Adagene Inc. American Depositary Shares
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ADAG Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of ADAG by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ADAG's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ADAG
Recent picks made for ADAG stock on CNBC
ETFs with the largest estimated holdings in ADAG
Flights by private jets registered to ADAG
![Quiver Logo](/static/img/logo-icon.png)